Brain & Behavior

Prof. Rafael Malach

Eye on the Brain

01.11.2003

Brain & Behavior

Understanding image-creating processes in the brain. Prof. Rafael Malach

Prof. Orly Reiner. Fateful Beginnings

Fateful Beginnings

01.11.2003

Brain & Behavior, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Evolution and Development, Genetics

At what stage in the development of an embryo does the brain begin to develop? And what can go wrong? Prof. Orly Reiner of the Molecular...

Prof. Yadin Dudai (center) with graduate students Mark Eisenberg and Tali Kobilo. Learning to forget

A Time to Remember, A Time to Forget

01.10.2003

Brain & Behavior

Bringing up a memory might help us to forget it

Deciphering Gaucher's Disease

Deciphering Gaucher's Disease

01.10.2003

Biochemistry, Brain & Behavior, Disease, Drugs & Diagnostics, Genetics, Structural Biology

New finding may lead to more effective – and affordable – treatments

Weizmann Institute Scientists Reveal a New Principle that Guides Memory Dynamics

Weizmann Institute Scientists Reveal a New Principle that Guides Memory Dynamics

21.08.2003

Brain & Behavior, Disease, Drugs & Diagnostics

The Finding May Lead To The Development Of New Treatments For Psychological Trauma

Call in the Taste Tailors

Call in the Taste Tailors

20.08.2003

Brain & Behavior, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Genetics

Why taste and smell differ among individuals – and how industry may profit “De gustibus non est disputandum” is a popular saying, conveying that...

Glucocerebrosidase

Weizmann Institute Scientists Solve the 3-D Structure of the Enzyme Involved in Gaucher Disease

02.06.2003

Biochemistry, Brain & Behavior, Disease, Drugs & Diagnostics, Structural Biology

The discovery may help design effective therapies for the genetic disease that mainly affects Ashkenazi Jews

X-Rays Yield Mechanism of Alzheimer’s Drug

X-Rays Yield Mechanism of Alzheimer’s Drug

01.05.2003

Biochemistry, Brain & Behavior, Disease, Drugs & Diagnostics, Structural Biology

A study of an Alzheimer's drug's activity reveals why lower doses might be just as effective

X-Rays Yield Mechanism of Alzheimer’s Drug

X-Rays Yield Mechanism of Alzheimer’s Drug

24.02.2003

Biochemistry, Brain & Behavior, Disease, Drugs & Diagnostics, Structural Biology

A team of Weizmann scientists has gained new insight into the effects of a newly approved drug, rivastigmine, in treating Alzheimer’s disease, a...

Prof. Joel Sussman, Prof. Ephraim Katzir, Prof. Sara Fuchs, Prof. Mati Fridkin. Top: Dr. Michal Harel, Dr. Moshe Balass, Dr. Tali Scherf, Dr. Roni Kasher

Biting Truths

01.05.2002

Biochemistry, Brain & Behavior, Immunology, Disease, Drugs & Diagnostics, Organic Chemistry, Structural Biology

Catching a snake toxin in the act may yield a host of medical applications

Pages

Top Stories

Shedding Light on the Dark Hours

Credit: Coleen Murphy, Princeton University, Princeton, NJ

Cracking the Code of a Worm's Throat

“Eight Shining Examples of Excellence”

Burning Cancer’s Bridges

Press Releases

“Eight Shining Examples of Excellence”

The Weizmann Institute of Science Ranked among the World’s Top Ten Academic Institutions

A Discovery to Set Your Heart a-Knocking